GBLX Projected Dividend Yield
GB Sciences Inc ( OTCBB : GBLX )GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable development partners that will assist it in preparing its cannabinoid-based formulas for the treatment of the motor symptoms of Parkinson's disease in human clinical trials. It is engaged in the research and development of plant-inspired medicines, with virtual operations in North America and Europe. 21 YEAR PERFORMANCE RESULTS |
GBLX Dividend History Detail GBLX Dividend News GBLX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |